Thinking Allowed
medical / technology / education / art / flub
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called "bad cholesterol," or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia.
Source: uk.reuters.com
cholesterol sanofi praluent drug anti-cholesterol low-density lipoprotein hypercholesterolemia
RSS feed